Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics Inc. buy Rodman & Renshaw

Start price
€0.54
09.03.26 / 50%
Target price
-
09.03.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.03.27. The prediction end date can be changed by Rodman___Renshaw at any time.
Performance without dividends (%)
Name 1w
Karyopharm Therapeutics Inc. -
iShares Core DAX® -6,02 %
iShares Nasdaq 100 0,51 %
iShares Nikkei 225® -7,16 %
iShares S&P 500 -0,26 %

Comments by Rodman___Renshaw for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren

Karyopharm Therapeutics (KPTI) is now covered by Rodman & Renshaw. They set a "buy" rating on the stock.
Ratings data for KPTI provided by MarketBeat